VACAVILLE, CA--(MARKET WIRE)--Dec 27, 2004 -- Large Scale Biology Corporation (NasdaqNM:LSBC - News) today announced receipt of Federal funds to expand the Company’s participation in national biowarfare defense initiatives. The $1 million award will be used to develop more effective candidate products for prevention and treatment of biowarfare-related illnesses.
